Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Margaret E. White"'
Autor:
Nichelle C. Whitlock, Margaret E. White, Brian J. Capaldo, Anson T. Ku, Supreet Agarwal, Lei Fang, Scott Wilkinson, Shana Y. Trostel, Zhen-Dan Shi, Falguni Basuli, Karen Wong, Elaine M. Jagoda, Kathleen Kelly, Peter L. Choyke, Adam G. Sowalsky
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-13 (2022)
Abstract Background The activities of MYC, the androgen receptor, and its associated pioneer factors demonstrate substantial reprogramming between early and advanced prostate cancer. Although previous studies have shown a shift in cellular metabolic
Externí odkaz:
https://doaj.org/article/5a0d34ef668f4038980d531db6603aef
Autor:
Jyoti Roy, Blake M. Warner, Falguni Basuli, Xiang Zhang, Changyu Zheng, Corrine Goldsmith, Tim Phelps, Karen Wong, Anita T. Ton, Rick Pieschl, Margaret E. White, Rolf Swenson, John A. Chiorini, Peter L. Choyke, Frank I. Lin
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Background PSMA-targeted radionuclide therapy (TRT) is a promising treatment for prostate cancer (PCa), but dose-limiting xerostomia can severely limit its clinical adaptation, especially when using alpha-emitting radionuclides. With [18F]DC
Externí odkaz:
https://doaj.org/article/cca22949d8694e11bdc75a8355c78adb
Autor:
Falguni Basuli, Xiang Zhang, Burchelle Blackman, Margaret E. White, Elaine M. Jagoda, Peter L. Choyke, Rolf E. Swenson
Publikováno v:
Molecules, Vol 24, Iss 13, p 2389 (2019)
To further explore the scope of our recently developed “fluorination on Sep-Pak” method, we prepared two well-known positron emission tomography (PET) tracers 21-[18F]fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-d
Externí odkaz:
https://doaj.org/article/24e12dca25e44a03a7d3eee4668d131c
Autor:
Margaret E. White, Thomas Pranzatelli, Xavier Moore, Joel Bowman, Jay Chiorini, Peter Choyke, Kathy Kelly
Publikováno v:
Cancer Research. 83:976-976
Prostate Specific Membrane Antigen (PSMA) is a prominent biomarker in Prostate Cancer (PC) and has evolved into a useful target for both imaging and therapy. But how PSMA becomes overexpressed upon PC development, its modulation by androgen deprivati
Autor:
Steven C. Ghivizzani, Margaret E. White, Eric P. Gibbs, Alison J. Morton, E. Viktoria Hyddmark, Mathew Winter, Michael J. Dark, David A. Myara, Yuan Lu, Christopher H. Evans, E. Anthony Dacanay, David M. Nickerson, Gregory B. Foremny, Patrick T. Colahan, Rice B, Elham Nasri, Ted A. Broome, Rachael S. Watson Levings, Ali Zarezadeh, Andrew D. Smith, Padraic P. Levings
Publikováno v:
Human Gene Therapy Clinical Development. 29:101-112
The authors are investigating self-complementary adeno-associated virus (scAAV) as a vector for intra-articular gene-delivery of interleukin-1 receptor antagonist (IL-1Ra), and its therapeutic capacity in the treatment of osteoarthritis (OA). To mode
Autor:
Margaret E. White, Michael J. Dark, Elham Nasri, E. Anthony Dacanay, David A. Myara, E. Viktoria Hyddmark, Padraic P. Levings, Rice B, Gregory B. Foremny, Ali Zarezadeh, Ted A. Broome, Christopher H. Evans, Steven C. Ghivizzani, Rachael S. Watson Levings, Yuan Lu, David M. Nickerson, Eric P. Gibbs, Andrew D. Smith, Patrick T. Colahan, Alison J. Morton, Mathew Winter
Toward the treatment of osteoarthritis (OA), the authors have been investigating self-complementary adeno-associated virus (scAAV) for intra-articular delivery of therapeutic gene products. As OA frequently affects weight-bearing joints, pharmacokine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2da6ab491ca06acafb1c2a6279650d2
https://europepmc.org/articles/PMC6007808/
https://europepmc.org/articles/PMC6007808/
Autor:
Alison Fleury, Christine Pilar, Margaret E. White, Stacey Frazier, Elizabeth Chase, Ivette F. Emery, Cindy Robinson, Douglas J. Weckstein, Barbara F. Shea, Christian A. Thomas
Publikováno v:
Journal of Oncology Practice. 7:330-333
Purpose: Less than 5% of patients with cancer participate in trials. Few studies have specifically addressed the role of cost to the patient as an influence on trial participation. Our main purpose was todeterminetheimportanceofaddedcostasabarriertoc
Autor:
Margaret E. White
Publikováno v:
Harrington Lesbian Literary Quarterly. 8:91-99
Publikováno v:
Cancer Research. 77:3087-3087
Osteosarcoma (OS) is a highly malignant bone cancer that is defined histologically by the secretion of immature osteoid. The chemotherapeutic regimen has not changed in the last 40 years and similarly, the five-year survival rate remains at ~60%, wit
Autor:
Elham Nasri, Charles P. Gibbs, S.C. Ghivizzani, Margaret E. White, Ali Zarezadeh, Maria V. Guijarro, Emma Viktoria Marie Hyddmark, Padraic P. Levings, Glyn D. Palmer
Publikováno v:
Cancer Research. 76:2432-2432
Osteosarcoma (OS) is a pediatric cancer with 40% mortality despite aggressive treatments. Major treatment challenges are that some tumors do not respond to therapies or develop resistance over time, processes partially attributed to cellular heteroge